Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients Compared to Non-Psoriatic Arthritis Patients

被引：0
|
作者：
Li, Lin [1 ]
Hagberg, Katrina W. [1 ]
Peng, Michael M. [2 ]
Jick, Susan [1 ]
机构：
[1] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
[2] Celgene, PV & Epidemiol, Berkeley Hts, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
835
引用
收藏
页码：448 / 448
页数：1
相关论文
共 50 条
  • [1] Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis
    Li, Lin
    Hagberg, Katrina Wilcox
    Peng, Michael
    Shah, Kamal
    Paris, Maria
    Jick, Susan
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2015, 21 (08) : 405 - 410
  • [2] Rates of Opportunistic Infections in Psoriatic Arthritis Patients Compared to Non-Psoriatic Arthritis Patients
    Hagberg, Katrina W.
    Li, Lin
    Peng, Michael M.
    Jick, Susan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 49 - 49
  • [3] Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
    Peluso, Rosario
    Caso, Francesco
    Tasso, Marco
    Ambrosino, Pasquale
    Di Minno, Matteo Nicola Dario
    Lupoli, Roberta
    Criscuolo, Livio
    Caso, Paolo
    Ursini, Francesco
    Del Puente, Antonio
    Scarpa, Raffaele
    Costa, Luisa
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 199 - 209
  • [4] Adverse Cardiovascular Events In Patients With Psoriasis And Psoriatic Arthritis
    Ottensoser, Molly
    Berger, Jeffrey
    Garshick, Michael S.
    [J]. CIRCULATION, 2022, 145
  • [5] Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis
    Kavadichanda, Chengappa
    Shanoj, K. C.
    Ganapathy, Sachit
    Shah, Sanket, I
    Ananthakrishnan, Ramesh
    Sahoo, Jayprakash
    Negi, Vir Singh
    [J]. RHEUMATOLOGY INTERNATIONAL, 2022, 42 (02) : 251 - 260
  • [6] RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN A SWISS COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLARTHRITIS
    Lauper, K.
    Chevallier-Ruggeri, P.
    Finckh, A.
    Gabay, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 702 - 703
  • [7] Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis
    Chengappa Kavadichanda
    K. C. Shanoj
    Sachit Ganapathy
    Sanket I. Shah
    Ramesh Ananthakrishnan
    Jayprakash Sahoo
    Vir Singh Negi
    [J]. Rheumatology International, 2022, 42 : 251 - 260
  • [8] Incidence and predictors for cardiovascular events in patients with psoriatic arthritis
    Eder, Lihi
    Wu, Ying
    Chandran, Vinod
    Cook, Richard
    Gladman, Dafna D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1680 - 1686
  • [9] UNDERESTIMATION OF CARDIOVASCULAR EVENTS BY CARDIOVASCULAR RISK SCORES IN PSORIATIC ARTHRITIS PATIENTS
    Lam, H. M.
    Ngai, S. H. O.
    Cho, S. H.
    Chun, T. K.
    Kot, K. L.
    Yim, C. T.
    Yu, E. F.
    Kun, E. W. L.
    Tam, L. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1019 - 1019
  • [10] Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
    Kristensen, Lars E.
    Strober, Bruce
    Poddubnyy, Denis
    Leung, Ying-Ying
    Jo, Hyejin
    Kwok, Kenneth
    Vranic, Ivana
    Fleishaker, Dona L.
    Fallon, Lara
    Yndestad, Arne
    Gladman, Dafna D.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
12345